Skip to main content
. Author manuscript; available in PMC: 2008 Apr 5.
Published in final edited form as: Regul Pept. 2006 Dec 28;140(1-2):12–20. doi: 10.1016/j.regpep.2006.11.020

Figure 5.

Figure 5

Kallikrein infusion reduces (A) JNK, p38MAPK and ERK phosphorylation. (B) Representative Western blot of phospho-IκB-α and IκB-α. GAPDH was used as an internal control. (C) Representative EMSA and (D) quantitative analyses of NF-κB DNA-binding activity. Values are expressed as mean ± SEM (n=6, *P<0.05 vs. MI & MI/TK+Icatibant).